Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Electra aims to light up Nasdaq with IPO for phase 2/3 I&I push

Electra aims to light up Nasdaq with IPO for phase 2/3 I&I push

  • August 31, 2026

The 2026 IPO streak continues as Electra Therapeutics has filed to go public to support its immunology and cancer pipeline.

Leave A Comment

Fields (*) Mark are Required